Clinical Trials

685 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT07131319 2026-02-02

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

Phase 2/3 Recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT01779206 2025-04-08

ADAPT

4,936 enrolled

Breast Neoplasms

NCT03081143 2024-12-12

RAMIRIS

429 enrolled

Advanced Gastric or EGJ Cancer

NCT05889390 2024-12-03

NeoHTerMa

71 enrolled

Hyperthermia, Breast Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

1,615 enrolled

Gynecologic

Endometrial Neoplasms

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

66 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02221999 2023-08-29

SHPD002

250 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT01057069 2022-10-12

neo-TN

310 enrolled

Breast Neoplasms

NCT00997906 2022-09-29

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Phase 2/3 Not yet recruiting

172 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

294 enrolled

Gynecologic

Endometrial Neoplasms

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

190 enrolled

HER2-positive Breast Cancer

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

Phase 2/3 Recruiting

260 enrolled

HER2-negative Breast Cancer

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Esophageal Squamous Cell Carcinoma

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

120 enrolled

The Neoadjuvant Therapy

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Esophageal Neoplasms

NCT00689715 2016-07-26

EUS-EP

50 enrolled

Neoplasms, Cystic, Mucinous, and Serous

NCT01426880 2016-02-15

GeparSixto

595 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT01196741 2015-05-05

SaPPrOC

107 enrolled 17 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02159820 2014-06-10

DAC and CT

500 enrolled

Other neoplasm

Primary Malignant Neoplasm of Ovary

NCT00752115 2011-09-07

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer